Literature DB >> 26915012

Endovascular Treatment of Infrapopliteal Peripheral Artery Disease.

Ehrin J Armstrong1, Kalkidan Bishu2, Stephen W Waldo2.   

Abstract

Endovascular treatment of infrapopliteal disease is focused on the treatment of patients with rest pain or critical limb ischemia (CLI) due to severe atherosclerotic disease. While the evidence base surrounding the comparative effectiveness of endovascular intervention vs. surgery is lacking, many operators have adopted an "endovascular first" approach to the treatment of infrapopliteal atherosclerotic disease due to the lower morbidity of these procedures. This manuscript reviews current data on the endovascular treatment of CLI, including a comparison of endovascular and surgical approaches, current indications for and outcomes with balloon angioplasty of infrapopliteal PAD, angiosome-guided revascularization, and emerging technologies to improve long-term vessel patency after endovascular intervention.

Entities:  

Keywords:  Balloon angioplasty; Critical limb ischemia; Endovascular intervention; Peripheral artery disease

Mesh:

Year:  2016        PMID: 26915012     DOI: 10.1007/s11886-016-0708-y

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  40 in total

1.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

2.  Two-year life expectancy in patients with critical limb ischemia.

Authors:  Yoshimitsu Soga; Osamu Iida; Mitsuyoshi Takahara; Mitsuyoshi Takahaera; Keisuke Hirano; Kenji Suzuki; Daizo Kawasaki; Yusuke Miyashita; Taketsugu Tsuchiya
Journal:  JACC Cardiovasc Interv       Date:  2014-12       Impact factor: 11.195

3.  Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: Analysis of amputation free and overall survival by treatment received.

Authors:  Andrew W Bradbury; Donald J Adam; Jocelyn Bell; John F Forbes; F Gerry R Fowkes; Ian Gillespie; Charles Vaughan Ruckley; Gillian M Raab
Journal:  J Vasc Surg       Date:  2010-05       Impact factor: 4.268

4.  SCAI expert consensus statement for infrapopliteal arterial intervention appropriate use.

Authors:  Bruce H Gray; Larry J Diaz-Sandoval; Robert S Dieter; Michael R Jaff; Christopher J White
Journal:  Catheter Cardiovasc Interv       Date:  2014-07-18       Impact factor: 2.692

Review 5.  Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials.

Authors:  Massimiliano Fusaro; Salvatore Cassese; Gjin Ndrepepa; Gunnar Tepe; Lamin King; Ilka Ott; Mateja Nerad; Heribert Schunkert; Adnan Kastrati
Journal:  JACC Cardiovasc Interv       Date:  2013-12       Impact factor: 11.195

6.  Endovascular recanalization of infrapopliteal occlusions in patients with critical limb ischemia.

Authors:  Gagan D Singh; Ehrin J Armstrong; Khung-Keong Yeo; Satinder Singh; Gregory G Westin; William C Pevec; David L Dawson; John R Laird
Journal:  J Vasc Surg       Date:  2014-01-03       Impact factor: 4.268

7.  Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial.

Authors:  Dimitris Siablis; Panagiotis M Kitrou; Stavros Spiliopoulos; Konstantinos Katsanos; Dimitris Karnabatidis
Journal:  JACC Cardiovasc Interv       Date:  2014-09       Impact factor: 11.195

8.  Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial.

Authors:  Andrew J Feiring; Mari Krahn; Lori Nelson; Amy Wesolowski; Daniel Eastwood; Aniko Szabo
Journal:  J Am Coll Cardiol       Date:  2010-04-13       Impact factor: 24.094

9.  Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial.

Authors:  Thomas Zeller; Iris Baumgartner; Dierk Scheinert; Marianne Brodmann; Marc Bosiers; Antonio Micari; Patrick Peeters; Frank Vermassen; Mario Landini; David B Snead; K Craig Kent; Krishna J Rocha-Singh
Journal:  J Am Coll Cardiol       Date:  2014-10-14       Impact factor: 24.094

Review 10.  Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia.

Authors:  Michael S Conte; Patrick J Geraghty; Andrew W Bradbury; Nathanael D Hevelone; Stuart R Lipsitz; Gregory L Moneta; Mark R Nehler; Richard J Powell; Anton N Sidawy
Journal:  J Vasc Surg       Date:  2009-11-07       Impact factor: 4.268

View more
  3 in total

1.  Prior Endovascular Intervention Is Not Detrimental to Pedal Bypasses for Ischemic Wounds.

Authors:  Abhisekh Mohapatra; Mikayla N Lowenkamp; Jon C Henry; Aureline Boitet; Efthimios D Avgerinos; Rabih A Chaer; Michel S Makaroun; Steven A Leers; Eric S Hager
Journal:  Ann Vasc Surg       Date:  2018-02-23       Impact factor: 1.466

2.  Bypass versus endovascular intervention for healing ischemic foot wounds secondary to tibial arterial disease.

Authors:  Abhisekh Mohapatra; Jon C Henry; Efthimios D Avgerinos; Aureline Boitet; Rabih A Chaer; Michel S Makaroun; Steven A Leers; Eric S Hager
Journal:  J Vasc Surg       Date:  2018-01-11       Impact factor: 4.268

Review 3.  [General Treatment Strategy for Intervention in Lower Extremity Arterial Disease].

Authors:  Je Hwan Won
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.